The Oropharyngeal Cancer Market was valued at USD 3.5 billion in 2024 and is projected to reach USD 6.8 billion by 2034, registering a CAGR of 7.0%. This growth trajectory is underpinned by several key factors, including the rising incidence of oropharyngeal cancer, advancements in treatment modalities, and increased awareness regarding early diagnosis and preventive measures. The global...